Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases

Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are considered the first line treatment for a subset of EGFR-mutated non-small cell lung cancer (NSCLC) patients. Although transformation to small cell lung cancer (SCLC) is one of the known mechanisms of resistanc...

Full description

Bibliographic Details
Main Authors: Soomin Ahn, Soo Hyun Hwang, Joungho Han, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn, Woong-Yang Park
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2016-07-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Lung neoplasms
Receptor, epidermal growth factor
Tyrosine kinase inhibitor
Small cell lung carcinoma
Adenocarcinoma
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2016-04-19.pdf

Internet

http://www.jpatholtm.org/upload/pdf/jptm-2016-04-19.pdf

Similar Items